Companies › RARE

ULTRAGENYX PHARMACEUTICAL IN (RARE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001515673 · EDGAR filings · Updated 2026-07-06

ULTRAGENYX PHARMACEUTICAL IN (RARE) has reported institutional ownership of 99.6%, with 294 institutional managers holding positions valued at $2.05B per the latest 13F reporting period.

Latest updates

• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Notice of proposed sale filed (Form 144)
• 2026-06-15 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ULTRAGENYX PHARMACEUTICAL IN has 294 institutional holders and institutional ownership of 99.6%.

Insider activity

Insiders reported 38 transactions (0 buys, 22 sells) across 15 reporting insiders, with a net reported value of −$3.24M.

Related companies

NEOGEN CORPORATION (NEOG) · AGIOS PHARMACEUTICALS INC (AGIO) · ADAPTIVE BIOTECHNOLOGIES COR (ADPT) · GENEDX HOLDINGS CORP COM CL A (WGS) · AMNEAL PHARMACEUTICALS INC (AMRX) · NEKTAR THERAPEUTICS (NKTR)